P-glycoprotein in blood-brain barrier endothelial cells:: interaction and oligomerization with caveolins

被引:89
作者
Jodoin, J
Demeule, M
Fenart, L
Cecchelli, R
Farmer, S
Linton, KJ
Higgins, CF
Béliveau, R
机构
[1] Univ Quebec, Hop St Justine, Mol Med Lab, Ctr Cancerol Charles Bruneau, Montreal, PQ H3C 3P8, Canada
[2] Univ Sci & Tech Lille Flandres Artois, Lab Mixte Inst Pasteur Lille, Lens, France
[3] Hammersmith Hosp, MRC, Ctr Clin Sci, London, England
关键词
blood-brain barrier; brain; caveolae; caveolin; endothelial cell; P-glycoprotein;
D O I
10.1046/j.1471-4159.2003.02081.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P-glycoprotein (P-gp), an adenosine triphosphate (ATP)-binding cassette transporter which acts as a drug efflux pump, is highly expressed at the blood-brain barrier (BBB) where it plays an important role in brain protection. Recently, P-gp has been reported to be located in the caveolae of multidrug-resistant cells. In this study, we investigated the localization and the activity of P-gp in the caveolae of endothelial cells of the BBB. We used an in vitro model of the BBB which is formed by co-culture of bovine brain capillary endothelial cells (BBCEC) with astrocytes. Caveolar microdomains isolated from BBCEC are enriched in P-gp, cholesterol, caveolin-1, and caveolin-2. Moreover, P-gp interacts with caveolin-1 and caveolin-2; together, they form a high molecular mass complex. P-gp in isolated caveolae is able to bind its substrates, and the caveolae-disrupting agents filipin III and nystatin decrease P-gp transport activity. In addition, mutations in the caveolin-binding motif present in P-gp reduced the interaction of P-gp with caveolin-1 and increased the transport activity of P-gp. Thus, P-gp expressed at the BBB is mainly localized in caveolae and its activity may be modulated by interaction with caveolin-1.
引用
收藏
页码:1010 / 1023
页数:14
相关论文
共 69 条
[31]   Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells [J].
Lavie, Y ;
Fiucci, G ;
Liscovitch, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :32380-32383
[32]   Upregulation of caveolin in multidrug resistant cancer cells: functional implications [J].
Lavie, Y ;
Fiucci, G ;
Liscovitch, M .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 49 (03) :317-323
[33]   Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences [J].
Lavie, Y ;
Liscovitch, M .
GLYCOCONJUGATE JOURNAL, 2000, 17 (3-4) :253-259
[34]   Mutational analysis of caveolin-induced vesicle formation - Expression of caveolin-1 recruits caveolin-2 to caveolae membranes [J].
Li, SW ;
Galbiati, F ;
Volonte', D ;
Sargiacomo, M ;
Engelman, JA ;
Das, K ;
Scherer, PE ;
Lisanti, MP .
FEBS LETTERS, 1998, 434 (1-2) :127-134
[35]   REDUCED PERMEABILITY IN CHO-CELLS AS A MECHANISM OF RESISTANCE TO COLCHICINE [J].
LING, V ;
THOMPSON, LH .
JOURNAL OF CELLULAR PHYSIOLOGY, 1974, 83 (01) :103-116
[36]   Multidrug resistance: a role for cholesterol efflux pathways? [J].
Liscovitch, M ;
Lavie, Y .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (11) :530-534
[37]   P-glycoprotein-actin association through ERM family proteins: a role in P-glycoprotein function in human cells of lymphoid origin [J].
Luciani, F ;
Molinari, A ;
Lozupone, F ;
Calcabrini, A ;
Lugini, L ;
Stringaro, A ;
Puddu, P ;
Arancia, G ;
Cianfriglia, M ;
Fais, S .
BLOOD, 2002, 99 (02) :641-648
[38]   Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains [J].
Luker, GD ;
Pica, CM ;
Kumar, AS ;
Covey, DF ;
Piwnica-Worms, D .
BIOCHEMISTRY, 2000, 39 (26) :7651-7661
[39]   Polarization distribution of endogenous Rac1 and RhoA at the cell surface [J].
Michaely, PA ;
Mineo, C ;
Ying, YS ;
Anderson, RGW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (30) :21430-21436
[40]   VIP21-CAVEOLIN, A MEMBRANE-PROTEIN CONSTITUENT OF THE CAVEOLAR COAT, OLIGOMERIZES IN-VIVO AND IN-VITRO [J].
MONIER, S ;
PARTON, RG ;
VOGEL, F ;
BEHLKE, J ;
HENSKE, A ;
KURZCHALIA, TV .
MOLECULAR BIOLOGY OF THE CELL, 1995, 6 (07) :911-927